The Healthcare Data

Metrion Biosciences Unveils Nav1.9 High-Throughput Screening Assay to Expand Pain Research and Enhance Screening Capabilities

Metrion Biosciences Launches High-Throughput NaV1.9 Screening Assay to Accelerate Non-Opioid Pain Therapeutics Research Metrion Biosciences (“Metrion”), a leading specialist preclinical contract research organisation (CRO) and globally recognised expert in ion channel research services, today announced the launch of its newly…

PCI Pharma to Acquire Ajinomoto Althea

PCI Pharma to Acquire Ajinomoto Althea PCI Pharma Services (PCI), a global leader in contract development and manufacturing (CDMO) focused on biopharmaceutical innovation, has announced the acquisition of Ajinomoto Althea, Inc. (Althea), a US-based sterile fill-finish CDMO. Althea is currently…